MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE174.403.8 (+2.23 %)
PREV CLOSE ( ) 170.60
OPEN PRICE ( ) 166.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 564556
TODAY'S LOW / HIGH ( )165.50 178.75
52 WK LOW / HIGH ( )70.2 185.4
NSE174.303.85 (+2.26 %)
PREV CLOSE( ) 170.45
OPEN PRICE ( ) 167.40
BID PRICE (QTY) 174.30 (5300)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4856047
TODAY'S LOW / HIGH( ) 165.25 178.65
52 WK LOW / HIGH ( )70.55 185.5
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax3376.532475.113021.641571.721043.07
Adjustment742.38353.07565.66420.38318.84
Changes In working Capital-1114.65-1107.02-1316.10591.17-817.92
Cash Flow after changes in Working Capital3004.261721.162271.202583.27543.99
Cash Flow from Operating Activities2374.12992.571785.902333.27273.95
Cash Flow from Investing Activities-2592.12-843.91-448.49-595.84-134.80
Cash Flow from Financing Activities1978.29795.11-152.85-1135.54-207.77
Net Cash Inflow / Outflow1760.29943.771184.56601.89-68.62
Opening Cash & Cash Equivalents2064.061120.29937.27335.38397.17
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations0.02NANANANA
Closing Cash & Cash Equivalent3824.372064.062121.83937.27328.55

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.